A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes
Clinical trial NCT00260156 · COMPLETED
Trial details
- NCT number
- NCT00260156
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2008-12-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.